A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Exclusion Criteria

• •Current evidence or history within the last 3 years of a neurological or psychiatric illness that could contribute to dementia, including, but not limited to: epilepsy, focal brain lesion, Parkinson's disease, seizure disorder, or head injury with loss of consciousness; DSM-IV-TR criteria for any major psychiatric disorder, including psychosis, major depression, and bipolar disorder.
• •Participation and dosing in another clinical trial, involving any marketed or investigational drug, within 30 days before Screening Visit.